Vimarsana
Biggest News Aggregation in the World

Page 23 - Patrick Malloy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patrick Malloy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patrick Malloy Today - Breaking & Trending Today

Arena Pharmaceuticals Inc (ARNA) Q1 2021 Earnings Call Transcript - Vimarsana News

Arena Pharmaceuticals Inc (ARNA) Q1 2021 Earnings Call Transcript

Good day, everyone, and welcome to Arena Pharmaceuticals Corporate Conference Call. [Operator Instructions] I will now turn the call over to Mr. Patrick Malloy, Vice President, Investor Relations at Arena Pharmaceuticals. Please go ahead, sir. Patrick Malloy -- Vice President, Investor Relations and Corporate Communications Great. Thank you, Delfin, and good afternoon, everyone. Thanks for joining us today, and we hope you had a chance to review the press release we issued this afternoon announcing our first quarter 2021 financial results. Joining me on today's call are Amit Munshi, our Pres...

Source: fool.com
Arena Pharmaceuticals presents late-breaking data on clinician and patient reported outcomes from.. - Vimarsana News

Arena Pharmaceuticals presents late-breaking data on clinician and patient reported outcomes from..

 E-Mail Etrasimod 2 mg treatment group achieved statistical significance in the percentage change in weekly peak pruritis (PP-NRS), in the change in Dermatology Life Quality Index (DLQI), and in the change in Patient-Oriented Eczema Measure (POEM) Etrasimod 2 mg was generally well tolerated, consistent with data in previous trials Park City, Utah, April 23, 2021 - Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced data at a late-breaking session at the American Academy of Dermatology VMX Experience. Etrasimod, a novel investigational drug candidate to treat moderate-to-severe atop...

Chicago Public Library to yank six Dr. Seuss books from shelves – HotAir - Vimarsana News

Chicago Public Library to yank six Dr. Seuss books from shelves – HotAir

NY Post Mar 09, 2021 11:37 AM ET A spokesman for the library told the Chicago Tribune Monday that the half-dozen children’s classics scrapped last week due to their alleged racism are already checked out, but won’t be offered up for loan once additional holds for the books are honored. “It is important to recognize that what society understands to be relevant and/or common knowledge changes over time, and so too does the Library and the needs of the communities it serves,” library spokesman Patrick Malloy told the newspaper in a statement. Malloy said staffers urge patrons of all ages...

Source: hotair.com
Arena Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 13 - Vimarsana News

Arena Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 13

Share this article Share this article SAN DIEGO, Dec. 22, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, is scheduled to present virtually at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021, at 10:00 AM ET. A live webcast of the presentation will be posted under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. About Arena Pharmaceuticals ARENA Pharmace...

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) News provided by Share this article Share this article SAN DIEGO, Dec. 18, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on December 15, 2020, the Compensation Committee of its Board of Directors granted to five new employees inducement stock options to purchase an aggregate of 141,975 shares of its common stock and 2,460 inducement restricted stock units ("RSUs"). The inducement stock options and RSUs have a grant date and vesting commencement date of December 15, 2020...